GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: QY-201 | QY201 | VVN-461 | VVN461
Compound class:
Synthetic organic
Comment: Quecitinib is the INN for a Janus kinase inhibitor with anti-inflammatory potential (INN proposed list 133, 10th July 2025). We have mapped this to the disclosed structure of clinical lead QY201, which is declared as an orally administered dual JAK1/TYK2 inhibitor [1]. The structure also matches the compound named VVN461 in patent WO2024221524A1 [2].
|
|
Bioactivity Comments |
None of the published information about this compound has included inhibitory potencies at its proposed molecular targets (JAK1 and TYK2). |